Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Amneal Pharmaceuticals Inc | AMRX | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
6,85 | 6,73 | 6,91 | 6,77 | 6,78 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
20.5.2024 | 22:10 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
16.5.2024 | 21:13 | EDGAR2 | Form 144 - Report of proposed sale of securities |
14.5.2024 | 22:38 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
13.5.2024 | 22:15 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
08.5.2024 | 22:46 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
25.1.2024 | 13:30 | GLOBE | Knight Therapeutics Enters into Exclusive License Agreement.. |
10.1.2024 | 13:03 | EDGAR2 | Form 8-K - Current report |
05.1.2024 | 22:09 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
03.1.2024 | 22:36 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
03.1.2024 | 22:30 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |